KRT88P and liver cancer: However, patients with isolated anti-HBc positivity exhibited higher mortality compared to patients with anti-HBc positivity associated with anti-HBs positivity: the liver-related mortality rate was 22.5 vs. 7 per 105 person-years, and the liver cancer mortality rate was 16.8 vs. 4.0 per 105 person-years.